4539 NIPPON CHEMIPHAR CO., LTD. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

4539

TSE Standard

NIPPON CHEMIPHAR CO., LTD.

1,664

JPY

-7

(-0.42%)

Oct 31, 3:30 pm JST

10.79

USD

Oct 31, 2:30 am EDT

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2022	32,506	825	1,022	700	194.3	50	May 13, 2022	J-GAAP
Mar, 2023	31,559	-241	58	339	94.1	50	May 12, 2023	J-GAAP
Mar, 2024	30,748	-494	-219	-180	-50.1	50	May 13, 2024	J-GAAP
Mar, 2025	32,570	606	443	294	81.7	50	May 14, 2025	J-GAAP
Mar, 2026 Guidance	35,000	300	100	150	41.6	50	May 14, 2025	J-GAAP
YoY	+7.5%	-50.5%	-77.4%	-49.0%	-49.1%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Mar, 2021	May 18, 2020	33,000	600	500	300	50	J-GAAP
	Oct 30, 2020	31,000	200	100	50	50	J-GAAP
Results	May 14, 2021	31,541	564	582	495	50	J-GAAP
Mar, 2022	May 14, 2021	Available in future release
	Jan 31, 2022
Results	May 13, 2022
Mar, 2023	May 13, 2022
	May 26, 2022
	Jan 31, 2023
	May 8, 2023
Results	May 12, 2023
Mar, 2024	May 12, 2023
	May 7, 2024
Results	May 13, 2024
Mar, 2025	May 13, 2024
Results	May 14, 2025
Mar, 2026	May 14, 2025	35,000	300	100	150	50	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Mar, 2001	18,806	-3.3	Available in future release
Mar, 2002	18,264	-2.9
Mar, 2003	18,559	+1.6
Mar, 2004	17,706	-4.6
Mar, 2005	20,162	+13.9
Mar, 2006	20,499	+1.7
Mar, 2007	20,966	+2.3
Mar, 2008	20,918	-0.2
Mar, 2009	22,307	+6.6
Mar, 2010	23,982	+7.5
Mar, 2011	27,361	+14.1
Mar, 2012	28,513	+4.2
Mar, 2013	31,944	+12.0
Mar, 2014	31,893	-0.2
Mar, 2015	35,118	+10.1
Mar, 2016	35,602	+1.4
Mar, 2017	35,689	+0.2
Mar, 2018	35,331	-1.0
Mar, 2019	34,182	-3.3
Mar, 2020	31,756	-7.1
Mar, 2021	31,541	-0.7
Mar, 2022	32,506	+3.1
Mar, 2023	31,559	-2.9
Mar, 2024	30,748	-2.6
Mar, 2025	32,570	+5.9
Mar, 2026 Guidance	35,000	+7.5	300	-50.5	100	-77.4	41.6	-49.1

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Mar, 2024	30,748	-494	-1.6	-0.97	-0.37	0.63	-50.1
Mar, 2025	32,570	606	1.86	1.56	0.59	0.66	81.7
Mar, 2026 Guidance	35,000	300	0.86	0.79	0.29	0.67	41.6

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	35,689	3,873	4,682	2,125	880.3
Fiscal Year	Mar, 2017	Mar, 2013	Mar, 1982	Mar, 2013	Mar, 1974

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2022	15,322	-408	-694	-557	-154.6	50	May 12, 2023	J-GAAP
Oct - Mar, 2023	15,911	-196	-229	-211	-58.8	50	May 13, 2024	J-GAAP
Oct - Mar, 2024	16,944	530	505	338	94.0	50	May 14, 2025	J-GAAP
Oct - Mar, 2025 Guidance	19,068	178	52	-13	-3.6	50	Oct 31, 2025	J-GAAP
YoY	+12.5%	-66.4%	-89.7%	－	－

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Mar, 2023	-241	-1,310	-916	-394	144	10,529	21.68	J-GAAP
Mar, 2024	-494	-2,843	296	-3,139	1,447	9,200	18.57	J-GAAP
Mar, 2025	606	-1,920	-265	-1,655	-305	7,021	14.08	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2023	14,837	-298	10	31	8.7	ー	Oct 31, 2023	J-GAAP
Apr - Sep, 2024	15,626	76	-62	-44	-12.3	ー	Oct 31, 2024	J-GAAP
Apr - Sep, 2025	15,932	122	48	163	45.3	48.0	Oct 31, 2025	J-GAAP
YoY	+2.0%	+60.5%	－	－	－

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2023	8,232	262	115	73	20.3	3.2	Jan 31, 2024	J-GAAP
Jan - Mar, 2024	7,679	-458	-344	-284	-79.1	-6.0	May 13, 2024	J-GAAP
Apr - Jun, 2024	7,996	3	161	126	35.1	0.0	Jul 31, 2024	J-GAAP
Jul - Sep, 2024	7,630	73	-223	-170	-47.4	1.0	Oct 31, 2024	J-GAAP
Oct - Dec, 2024	8,681	279	411	79	22.2	3.2	Jan 31, 2025	J-GAAP
Jan - Mar, 2025	8,263	251	94	259	72.0	3.0	May 14, 2025	J-GAAP
Apr - Jun, 2025	8,248	232	148	227	63.0	2.8	Jul 31, 2025	J-GAAP
Jul - Sep, 2025	7,684	-110	-100	-64	-17.8	-1.4	Oct 31, 2025	J-GAAP
YoY	+0.7%	－	+55.2%	+62.4%	+62.5%

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2020	8,780	+7.5	Available in future release
Jan - Mar, 2021	7,929	+5.9
Apr - Jun, 2021	7,575	+5.3
Jul - Sep, 2021	8,000	+4.8
Oct - Dec, 2021	9,152	+4.2
Jan - Mar, 2022	7,779	-1.9
Apr - Jun, 2022	8,425	+11.2
Jul - Sep, 2022	7,812	-2.4
Oct - Dec, 2022	7,778	-15.0
Jan - Mar, 2023	7,544	-3.0
Apr - Jun, 2023	7,537	-10.5
Jul - Sep, 2023	7,300	-6.6
Oct - Dec, 2023	8,232	+5.8
Jan - Mar, 2024	7,679	+1.8
Apr - Jun, 2024	7,996	+6.1
Jul - Sep, 2024	7,630	+4.5
Oct - Dec, 2024	8,681	+5.5
Jan - Mar, 2025	8,263	+7.6
Apr - Jun, 2025	8,248	+3.2
Jul - Sep, 2025	7,684	+0.7	-110	－	-100	+55.2	-17.8	+62.4

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	9,720	1,225	1,231	1,368	358.2
Fiscal Year	Dec, 2017	Dec, 2011	Dec, 2016	Dec, 2005	Dec, 2005

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Mar, 2023	5,130.65	38.1	48,571	18,517	13,636	0.82	May 12, 2023	J-GAAP
Mar, 2024	5,116.02	37.3	49,548	18,460	13,273	0.92	May 13, 2024	J-GAAP
Mar, 2025	5,312.46	38.4	49,851	19,167	13,432	0.94	May 14, 2025	J-GAAP
Apr - Sep, 2025	5,247.90	36.4	51,986	18,933	13,412	0.96	Oct 31, 2025	J-GAAP

NIPPON CHEMIPHAR CO., LTD.(4539) Financial Results